Elspar - Drug Details
๐Ÿ“Š Estimates Elspar Dialyzability By Different_Modalities

Elspar

Complete Drug Information

Drug Name
Elspar
Trade Names
Elspar, Leunase, Rylaze, Spectrila
Pregnancy Category
AU: D
Routes of Administration
Intramuscular, intravenous
Elimination
39-49 hours (IM), 8-30 hours (IV)
Formula
C1377H2208N382O442S17
Molar Mass
31732.06
Drug Class
Antineoplastic
Volume of Distribution
C1377H2208N382O442S17

๐Ÿคฐ Pregnancy Category Information

Category: AU: D

Drugs which have caused, are suspected to have caused, or may be expected to cause an increased incidence of human fetal malformations or irreversible damage. These drugs may also have adverse pharmacological effects.